KIAA0953 Inhibitors
Chemical inhibitors of KIAA0953 can significantly impair the protein's function by disrupting various cellular pathways and mechanisms. Bafilomycin A1, a specific inhibitor of V-ATPase, affects the acidification of endosomes, which is a critical step for the proper signaling and trafficking within cells. Since KIAA0953 is involved in the regulation of phosphatidylinositol 4-kinase activity, the disruption of endosomal function by Bafilomycin A1 can lead to a downstream inhibition of KIAA0953's role in these pathways. Similarly, Wortmannin and LY294002 both target the PI3K pathway, an upstream regulator of PI4K activity. By inhibiting PI3K, these chemicals reduce the levels of PIP3, a precursor required for PI4K function, thereby indirectly affecting the activity of KIAA0953. ML-9, by inhibiting MLCK, can affect the cellular transport and localization of KIAA0953, while Dynasore's inhibition of dynamin, a GTPase essential for endocytosis, can impede the endocytic pathways that KIAA0953 relies on for its membrane-associated functions.
In addition to these inhibitors, Endosidin2 targets the ESCRT machinery, which plays a role in endosomal trafficking. This can disrupt the membrane dynamics that KIAA0953 is associated with. Phenylarsine oxide (PAO) interferes with proteins involved in vesicle trafficking and fusion, processes that are key to the roles played by KIAA0953 in cellular signaling. Hydroxychloroquine disrupts endosomal-lysosomal pathways by increasing the endosomal pH, again affecting the environment critical for KIAA0953's activity. GW4869 prevents the formation of ceramide by inhibiting neutral sphingomyelinase, potentially altering membrane composition and trafficking that can influence KIAA0953's functionality. Genistein, as a tyrosine kinase inhibitor, can alter signaling pathways by preventing phosphorylation, which may affect KIAA0953's activity. Lastly, Okadaic Acid, which inhibits protein phosphatases PP1 and PP2A, can maintain certain proteins in a phosphorylated state, potentially affecting the localization and function of KIAA0953 within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 is a specific inhibitor of vacuolar-type H+ ATPase (V-ATPase). Since KIAA0953 is involved in the regulation of phosphatidylinositol 4-kinase (PI4K) activity, and V-ATPase is crucial for endosomal acidification which is necessary for endosome-mediated signaling pathways, inhibition of V-ATPase by Bafilomycin A1 can disrupt endosomal function, thereby indirectly inhibiting KIAA0953's associated pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of phosphoinositide 3-kinases (PI3K). Given that PI3K is part of the pathway that generates phosphatidylinositol (3,4,5)-trisphosphate (PIP3) from phosphatidylinositol (4,5)-bisphosphate (PIP2), and KIAA0953 is associated with PI4K activity, inhibiting PI3K can decrease PIP3 levels, thus reducing the substrate availability for PI4K and consequently inhibiting KIAA0953 function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is another PI3K inhibitor that prevents the phosphorylation of PIP2 to PIP3. By inhibiting this upstream pathway, the production of PIP3 is reduced, which is necessary for the PI4K-related functions, leading to an indirect inhibition of KIAA0953's role in the PI4K pathway. | ||||||
ML-9 | 105637-50-1 | sc-200519 sc-200519A sc-200519B sc-200519C | 10 mg 50 mg 100 mg 250 mg | $112.00 $449.00 $673.00 $1224.00 | 2 | |
ML-9 is an inhibitor of myosin light-chain kinase (MLCK). As MLCK is involved in cellular transport mechanisms that may be required for the proper localization and function of KIAA0953, its inhibition by ML-9 can impede the cellular trafficking necessary for KIAA0953 activity. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore is a GTPase inhibitor that targets dynamin, preventing endocytosis. KIAA0953, through its involvement in PI4K activity, is likely to be involved in membrane trafficking processes that are dependent on endocytosis. Therefore, inhibiting dynamin with Dynasore can impede the endocytic pathways essential for KIAA0953 function. | ||||||
hydroxychloroquine | 118-42-3 | sc-507426 | 5 g | $57.00 | 1 | |
Hydroxychloroquine, known to raise endosomal pH, can disrupt the endosomal-lysosomal pathway. As KIAA0953 is involved in cellular processes associated with endosomal signaling, increasing endosomal pH with Hydroxychloroquine can disrupt these pathways, thereby inhibiting KIAA0953's function. | ||||||
GW4869 | 6823-69-4 | sc-218578 sc-218578A | 5 mg 25 mg | $203.00 $611.00 | 24 | |
GW4869 is a neutral sphingomyelinase (nSMase) inhibitor, which can prevent the formation of ceramide, a molecule involved in vesicle formation and trafficking. Inhibition of nSMase could result in altered membrane composition and trafficking, affecting the functional pathways where KIAA0953 is active. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor and by inhibiting tyrosine kinases, which can phosphorylate various proteins involved in signaling pathways, it may alter the signaling pathways that KIAA0953 is part of, thereby inhibiting its function. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases PP1 and PP2A. Phosphorylation state of proteins is crucial for their activity and localization. By maintaining phosphorylated states of certain proteins, okadaic acid could indirectly inhibit KIAA0953 by affecting its placement and function within the cell. | ||||||